Sonova Holding AG reported a 3.9% beat on normalized profit estimates for its 2025-26 fiscal year.
Normalized EBITA reached CHF 811.2 million, exceeding the consensus estimate of CHF 780.8 million.
Sales were in line with expectations at CHF 3.61 billion.
The company noted strong performance despite headwinds in China, particularly in the Cochlear Implants segment.












